it is likely that the model predictions reflect more clinically significant disease risks. This may also partly explain the underpredicted risks in UK Biobank, before recalibration. However, further research is needed on genetic predictors for aggressive PCa and on validating the prediction of specifically aggressive PCa risks. The model does not incorporate nonfamilial/nongenetic factors, such as PSA or other clinical measurements.
Joe Dennis, Naomi Wilcox, Tokhir Dadaev, Koveela Govindasami, Goska Leslie, Kenneth Muir, Elizabeth Bancroft, Zsofia Kote-Jarai, Rosalind EelesTommy Nyberg, Mark N. Brook, Lorenzo Ficorella, Andrew Lee, Xin Yang, Koveela Govindasami, Michael Lush, Douglas F. Easton, Zsofia Kote-Jarai, Antonis C. Antoniou
physorg_com Cambridge_Uni 👍👍👍
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Perceived Benefit or Burden of Research Participation and Withdrawal From Cancer TrialsThis survey study analyzes the association of patients' perceived benefits and burdens of research participation with retention in cancer clinical trials.
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: MetroUK - 🏆 13. / 82 Read more »
Source: TheSun - 🏆 64. / 61 Read more »
Source: LiveLancs - 🏆 10. / 87 Read more »
Source: LiveLancs - 🏆 10. / 87 Read more »
Source: MetroUK - 🏆 13. / 82 Read more »